Cohen & Steers Inc.
Rating
Updated: Aug 29, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Cohen & Steers, Inc. operates as a publicly traded holding company specializing in asset management. Through its various operating units, the firm delivers financial services to institutional investor...
Latest News
7 days ago · prnewswire.com
Corero Network Security Named Best in Channel-First Cybersecurity Distribution at CybersecAsia Readers' Choice Awards 2026Recognition Reflects Corero's Channel-First Strategy and Growing Partner Ecosystem LONDON, Sept. 15, 2026 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service ("DDoS") protection specialists and champion of adaptive, real-time service availability, today announced it has been named Best in Channel-First Cybersecurity Distribution at the CybersecAsia Readers' Choice Awards 2026.
12 days ago · globenewswire.com
Pasqal and LG CNS partner to power Next-generation AI Data centers with quantum computingOn the sidelines of the France-Korea State Visit, Pasqal strengthens its long-term presence in South Korea by signing a three-year MoU with LG CNS to develop scalable hybrid AI and quantum computing platforms. On the sidelines of the France-Korea State Visit, Pasqal strengthens its long-term presence in South Korea by signing a three-year MoU with LG CNS to develop scalable hybrid AI and quantum computing platforms.
13 days ago · prnewswire.com
Cohen & Steers Announces Preliminary Assets Under Management and Net Flows for August 2026NEW YORK, Sept. 9, 2026 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) today reported preliminary assets under management of $101.0 billion at August 31, 2026, a decrease of $1.5 billion from assets under management of $102.5 billion at July 31, 2026.
20 days ago · proactiveinvestors.co.uk
Corero spikes 10% on $3.9 million UK telecom and NeoCloud dealsShares in Corero Network Security PLC (AIM:CNS, OTCQB:DDOSF) rose 10% to 8p after itech vendor secured a combined $3.9 million in new agreements to deploy its sovereign cybersecurity defences across the UK telecommunications sector and the global NeoCloud sector. At the heart of the operational update is a pivotal five-year contract worth $3.4 million with a leading UK-based tier 1 fixed and mobile telecommunications provider.
21 days ago · accessnewswire.com
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of GrowthChief Business Officer, Dylan Wenke, Participates in Virtual Investor "What This Means" Segment Access the segment here HOUSTON, TX / ACCESS Newswire / September 1, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in a Virtual Investor "What This Means" Segment. Dylan Wenke, Chief Business Officer of CNS Pharmaceuticals, provided an update on its business development strategy as part of its broader transformation as the Company works to establish a pipeline focused on oncology or neurology with best in class potential.
22 days ago · prnewswire.com
Cohen & Steers and Trademark Acquire Oak Hill Plaza Shopping Center in Austin, TexasNEW YORK, Aug. 31, 2026 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that the Cohen & Steers Real Estate Opportunities Fund (REOF) has acquired Oak Hill Plaza, a shopping center in Austin, Texas. The acquisition was made through a joint venture with Trademark Property Company, a real estate investor, developer, and operator with expertise in retail assets in Texas.
26 days ago · accessnewswire.com
CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand ConferenceVideo webcast now available here HOUSTON, TX / ACCESS Newswire / August 27, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it participated in the Virtual Investor "Why Now" on-demand conference. Rami Levin, President and Chief Executive Officer of CNS Pharmaceuticals, highlighted the Company's strategic transformation that is being built on the strength of its newly assembled executive leadership team, enhanced financial position following its recent financing, and disciplined approach to evaluating differentiated assets.
1 month ago · globenewswire.com
Cerenome Highlights Presentations at the 2026 SNO/ASCO CNS Metastases Conference Demonstrating Progress in Both Therapeutics and Diagnostics Business LinesCerenome highlights SNO/ASCO data showing REYOBIQ CSF distribution and safety, and CNSide's potential to reduce monthly LM treatment costs by up to 47%.
1 month ago · prnewswire.com
Corero Network Security Launches AI-Augmented Cloud-Assist for SmartWall ONE™Combining Cloud-Scale AI Analysis With Human Expertise for Enhanced Threat Responses LONDON, Aug. 20, 2026 /PRNewswire/ -- Corero Network Security (AIM: CNS) (OTCQX: DDOSF), the distributed denial of service ("DDoS") protection specialists and champion of adaptive, real-time service availability, today announced AI-Augmented Cloud-Assist for SmartWall ONE™, extending its automated DDoS protection with cloud-delivered AI analysis, threat intelligence, and policy optimization. As cybercriminals increasingly leverage AI to develop and evolve attack campaigns, defenders must respond with equal speed and precision.
1 month ago · prnewswire.com
Cohen & Steers and DLC Acquire Royal Plaza Grocery Shopping Center in Front Royal, VirginiaNEW YORK, Aug. 17, 2026 /PRNewswire/ -- Cohen & Steers (NYSE: CNS) announced today that the Cohen & Steers Real Estate Opportunities Fund (REOF) has acquired Royal Plaza, a grocery-anchored center in Front Royal, Va., part of the Washington D.C.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CNS